Identification of the molecular basis of doxorubicin-induced cardiotoxicity (original) (raw)

Nature Medicine volume 18, pages 1639–1642 (2012)Cite this article

Subjects

Abstract

Doxorubicin is believed to cause dose-dependent cardiotoxicity through redox cycling and the generation of reactive oxygen species (ROS). Here we show that cardiomyocyte-specific deletion of Top2b (encoding topoisomerase-IIβ) protects cardiomyocytes from doxorubicin-induced DNA double-strand breaks and transcriptome changes that are responsible for defective mitochondrial biogenesis and ROS formation. Furthermore, cardiomyocyte-specific deletion of Top2b protects mice from the development of doxorubicin-induced progressive heart failure, suggesting that doxorubicin-induced cardiotoxicity is mediated by topoisomerase-IIβ in cardiomyocytes.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Accession codes

Primary accessions

Gene Expression Omnibus

References

  1. Yeh, E.T. & Bickford, C.L. J. Am. Coll. Cardiol. 53, 2231–2247 (2009).
    Article CAS Google Scholar
  2. Force, T. & Kolaja, K.L. Nat. Rev. Drug Discov. 10, 111–126 (2011).
    Article CAS Google Scholar
  3. Tewey, K.M., Rowe, T.C., Yang, L., Halligan, B.D. & Liu, L.F. Science 226, 466–468 (1984).
    Article CAS Google Scholar
  4. Capranico, G., Tinelli, S., Austin, C.A., Fisher, M.L. & Zunino, F. Biochim. Biophys. Acta 1132, 43–48 (1992).
    Article CAS Google Scholar
  5. Lyu, Y.L. et al. Mol. Cell. Biol. 26, 7929–7941 (2006).
    Article CAS Google Scholar
  6. Singal, P.K. & Iliskovic, N. N. Engl. J. Med. 339, 900–905 (1998).
    Article CAS Google Scholar
  7. Myers, C. et al. Semin. Oncol. 10, 53–55 (1983).
    CAS PubMed Google Scholar
  8. Martin, E. et al. Toxicology 255, 72–79 (2009).
    Article CAS Google Scholar
  9. Lyu, Y.L. et al. Cancer Res. 67, 8839–8846 (2007).
    Article CAS Google Scholar
  10. Lyu, Y.L. & Wang, J.C. Proc. Natl. Acad. Sci. USA 100, 7123–7128 (2003).
    Article CAS Google Scholar
  11. Sohal, D.S. et al. Circ. Res. 89, 20–25 (2001).
    Article CAS Google Scholar
  12. Okamura, S. et al. Mol. Cell 8, 85–94 (2001).
    Article CAS Google Scholar
  13. Ogasawara, J. et al. Nature 364, 806–809 (1993).
    Article CAS Google Scholar
  14. Plesca, D., Mazumder, S. & Almasan, A. Methods Enzymol. 446, 107–122 (2008).
    Article CAS Google Scholar
  15. Arany, Z. et al. Proc. Natl. Acad. Sci. USA 103, 10086–10091 (2006).
    Article CAS Google Scholar
  16. Lai, L. et al. Genes Dev. 22, 1948–1961 (2008).
    Article CAS Google Scholar
  17. Wang, J. et al. Circ. Res. 106, 1904–1911 (2010).
    Article CAS Google Scholar
  18. Wallace, K.B. Pharmacol. Toxicol. 93, 105–115 (2003).
    Article CAS Google Scholar
  19. Sahin, E. et al. Nature 470, 359–365 (2011).
    Article CAS Google Scholar
  20. Ju, B.G. et al. Science 312, 1798–1802 (2006).
    Article CAS Google Scholar
  21. Liao, R. & Jain, M. Methods Mol. Med. 139, 251–262 (2007).
    Article Google Scholar
  22. Bawa-Khalfe, T., Cheng, J., Wang, Z. & Yeh, E.T. J. Biol. Chem. 282, 37341–37349 (2007).
    Article CAS Google Scholar
  23. Ishii, K.A. et al. Nat. Med. 15, 259–266 (2009).
    Article CAS Google Scholar
  24. Zeisberg, E.M. et al. Nat. Med. 13, 952–961 (2007).
    Article CAS Google Scholar

Download references

Acknowledgements

We thank C.H. Ren for expert technical assistance and F.M. Lin and H. Dou for conducting studies on mitochondria DNA. W.C. Claycomb (Louisiana State University Health Science Center) provided HL-1 cells. This study is supported by the Cancer Prevention Research Institute of Texas and McNair Medical Institute (E.T.H.Y.), US National Institutes of Health grant CA102463 (to L.F.L.), the New Jersey Commission on Cancer Research Grant 06-2419-CCR-EO, US Department of Defense Idea Award W81XWH-07-1-0407 and Concept Award W81XWH06-1-0514 (to Y.L.L.).

Author information

Authors and Affiliations

  1. Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Sui Zhang, Tasneem Bawa-Khalfe & Edward T H Yeh
  2. Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas, USA
    Xiaobing Liu, Long-Sheng Lu & Edward T H Yeh
  3. Department of Vascular Surgery, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
    Xiaobing Liu
  4. Department of Pharmacology, University of Medicine and Dentistry of New Jersey—Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
    Yi Lisa Lyu & Leroy F Liu

Authors

  1. Sui Zhang
    You can also search for this author inPubMed Google Scholar
  2. Xiaobing Liu
    You can also search for this author inPubMed Google Scholar
  3. Tasneem Bawa-Khalfe
    You can also search for this author inPubMed Google Scholar
  4. Long-Sheng Lu
    You can also search for this author inPubMed Google Scholar
  5. Yi Lisa Lyu
    You can also search for this author inPubMed Google Scholar
  6. Leroy F Liu
    You can also search for this author inPubMed Google Scholar
  7. Edward T H Yeh
    You can also search for this author inPubMed Google Scholar

Contributions

E.T.H.Y. and L.F.L. conceived the project. S.Z., X.L., T.B.-K., L.-S.L. and Y.L.L. performed experiments and data analysis. E.T.H.Y. and S.Z. wrote the manuscript with editorial input from L.F.L. and Y.L.L.

Corresponding author

Correspondence toEdward T H Yeh.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

About this article

Cite this article

Zhang, S., Liu, X., Bawa-Khalfe, T. et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity.Nat Med 18, 1639–1642 (2012). https://doi.org/10.1038/nm.2919

Download citation

This article is cited by